This bill amends New Jersey law to eliminate pre-authorization requirements for diabetes-related equipment and supplies, ensuring that individuals have direct access to necessary treatments. It mandates that all health insurance policies, including those from hospital service corporations and medical service corporations, cover essential diabetes supplies such as blood glucose monitors, insulin, and syringes without imposing prior authorization or other prospective utilization management requirements. Additionally, the bill specifies that coverage for insulin products will not be subject to any deductible, and copayments or coinsurance for insulin will not exceed $35 per 30-day supply.

Furthermore, the bill emphasizes the importance of diabetes self-management education, requiring that health benefits plans provide coverage for such education delivered by qualified professionals, including registered dietitians and certified diabetes educators. This education must be offered to the same extent as for any other medical condition under the health benefits plan. The provisions of the bill apply to high-deductible health plans and catastrophic plans, as permitted by federal law, and the Commissioner of Banking and Insurance is authorized to update a list of necessary diabetes equipment and supplies as needed. The act will take effect four months after its enactment and will apply to policies and contracts issued or renewed thereafter.

Statutes affected:
Introduced: 17:48-6, 17:48A-7, 17:48E-35.11, 17B:26-2.1, 17B:35-46.1, 17B:27A-7.31, 17B:27A-19.35, 52:14-17.29, 52:14-17.46.6